Clinical correlates of false-negative fine needle aspirations of the breast in a consecutive series of 1,005 patients.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 8460412)

Published in Surg Gynecol Obstet on April 01, 1993

Authors

F O'Malley1, T T Casey, A C Winfield, W H Rodgers, J Sawyers, D L Page

Author Affiliations

1: Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232.

Articles by these authors

Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med (1985) 7.22

Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology (1976) 6.15

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67

BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26

Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer (1985) 3.92

Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol (2000) 3.55

Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol (1992) 3.39

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer (1993) 3.33

Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14

Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med (1994) 3.09

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91

Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med (1991) 2.77

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med (1995) 2.74

Myocardial changes associated with cardiogenic shock. N Engl J Med (1971) 2.67

Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol (1996) 2.50

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33

Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32

Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27

Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol (1992) 2.18

Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer (1982) 2.17

Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07

Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med (1991) 2.06

American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02

Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98

Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol (1976) 1.97

Invasive breast cancer risk in women with sclerosing adenosis. Cancer (1989) 1.93

Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog (1994) 1.92

Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol (1997) 1.91

Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol (2000) 1.88

Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst (1978) 1.82

Exploration of factors affecting mammography behaviors. Prev Med (1988) 1.77

Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77

When and to what end do pathologists agree? J Natl Cancer Inst (1998) 1.76

Minimal solid tumor involvement of regional and distant sites: when is a metastasis not a metastasis? Cancer (1999) 1.73

Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68

Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst (1999) 1.67

Histologic grading of breast carcinoma. A reproducibility study. Cancer (1994) 1.61

Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest (1985) 1.54

Invasive cribriform carcinoma of the breast. Histopathology (1983) 1.53

Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest (1973) 1.51

Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol (2000) 1.45

Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol (2001) 1.44

Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild. JAMA (1996) 1.42

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol (2000) 1.42

Recurrent mammary carcinoma after local excision. A segmental problem. Cancer (1995) 1.41

Cellular proliferation and prognosis in breast cancer: statistical purity versus clinical utility. Hum Pathol (1994) 1.41

Immunochemical cross-reactions of human amyloid proteins with human immunoglobulin light polypeptide chains. J Immunol (1972) 1.39

American Cancer Society's Breast Cancer Detection Awareness Program: the 1988 middle Tennessee experience. South Med J (1990) 1.39

Long-term survivors after breast cancer. Br J Surg (1985) 1.38

Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer (1989) 1.36

The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem (1972) 1.32

The development of cardiac myxomas and papillary endocardial lesions from mural thrombus. Am Heart J (1975) 1.31

Infarction of bone marrow in the sickle cell disorders. Ann Intern Med (1967) 1.30

Adenomas of the breast and ectopic breast under lactational influences. Hum Pathol (1985) 1.26

Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol (1987) 1.25

Murine amyloidosis: immunologic characterization of amyloid fibril protein. J Immunol (1971) 1.25

Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J Natl Cancer Inst (2000) 1.24

Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol (1987) 1.22

Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol (1979) 1.22

IgA deficiency associated with partial deletion of chromosome 18. Am J Dis Child (1969) 1.20

Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest (1997) 1.18

No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer (2001) 1.17

College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. Arch Pathol Lab Med (2000) 1.17

Diabetic mastopathy. A clinicopathologic review. Am J Clin Pathol (2000) 1.15

Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer (1999) 1.15

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer (1994) 1.15

Comparison of adrenal cortical tumors in children and adults. Cancer (1986) 1.14

Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A (1995) 1.13

Optical properties of normal and diseased breast tissues: prognosis for optical mammography. J Biomed Opt (1996) 1.13

Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berl) (1972) 1.11

Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol (1988) 1.10

College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee. Arch Pathol Lab Med (1995) 1.10

Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr (1994) 1.09

Staphylococcal bacteremia and altered host resistance. Ann Intern Med (1968) 1.08

Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Cancer Res (1986) 1.08

Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes. Am J Med (1971) 1.07

Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci U S A (1986) 1.07

Retinoic acid binding protein: occurrence in human tumors. Science (1975) 1.05

Atrial arrhythmias and lipomatous hypertrophy of the cardiac interatrial septum. Am Heart J (1971) 1.05

Detergent enema: a cause of caustic colitis. Pediatr Radiol (1977) 1.04

Surgical management of Menetrier's disease with protein-losing gastropathy. Ann Surg (1975) 1.04

Immunolocalization of transforming growth factor-alpha in normal and diseased human gastric mucosa. Hum Pathol (1995) 1.03

Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A (1994) 1.03

Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Mod Pathol (1998) 1.03

Mesenchymal hamartoma of liver. A regional ischemic lesion of a sequestered lobe. Am J Dis Child (1993) 1.02

Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol (2001) 1.02

Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease. Hum Pathol (1986) 1.01

Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer (1995) 1.01

Bacteriological studies in a patient with antibiotic-associated pseudomembranous colitis. Gastroenterology (1977) 1.01

Color Doppler sonography of benign and malignant ovarian masses. Radiographics (1992) 1.01

Epithelioid variant of malignant peripheral nerve sheath tumor (malignant schwannoma) of the urinary bladder. Ann Diagn Pathol (1999) 1.00

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol (2001) 1.00

Connective tissue abnormalities in spontaneous rupture of chordae tendineae. Arch Pathol (1971) 1.00

ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. Lab Invest (1986) 1.00

Pheochromocytoma. Curr Probl Surg (1974) 0.99

Carcinosarcoma of the uterus associated with a nongestational choriocarcinoma. South Med J (2000) 0.99

Aortic intimal sarcoma with embolic metastases. Am J Surg Pathol (1985) 0.99

Inhomogeneous distribution of egg RNA sequences in the early embryo. Cell (1978) 0.99